Outpatient Treatment of Group B Streptococcus Urinary Tract Infection
For outpatient treatment of Group B Streptococcus (GBS) urinary tract infection, use oral amoxicillin 500 mg three times daily or penicillin V 500 mg four times daily for 7-10 days, as GBS remains universally susceptible to penicillins. 1
First-Line Antibiotic Selection
- Penicillins are the drugs of choice for GBS UTI due to their narrow spectrum, universal susceptibility, and low cost 2, 1
- Oral amoxicillin 500 mg three times daily is preferred over penicillin V due to better bioavailability and simpler dosing 2
- Penicillin V 500 mg four times daily is an acceptable alternative 2
- All GBS isolates tested in clinical studies showed 100% susceptibility to penicillins, ampicillin, and cephalosporins 1
Treatment Duration
- 7-10 days of therapy is recommended for GBS UTI, consistent with treatment of complicated UTI caused by gram-positive organisms 3, 4
- This duration is longer than the 3-5 days used for uncomplicated E. coli cystitis 4
- The extended duration accounts for GBS being associated with underlying urinary tract abnormalities in 60% of cases 1
Penicillin-Allergic Patients
For patients with documented penicillin allergy:
- First-generation cephalosporins (cephalexin 500 mg twice daily for 10 days) can be used in patients without history of anaphylaxis, angioedema, or urticaria 2, 5
- Avoid cephalosporins entirely in patients with immediate-type hypersensitivity reactions 5
- For high-risk penicillin allergy, consider clindamycin 300 mg three times daily if susceptibility testing confirms sensitivity 2, 5
- Note that erythromycin resistance rates in GBS can be high (36.3%), and clindamycin resistance occurs in 26% of isolates 6
Critical Clinical Considerations
When to Investigate Further
- Screen for urinary tract abnormalities in all patients with GBS UTI, as 60% have underlying structural problems and 27% have chronic renal failure 1
- GBS bacteriuria signals the need for urologic evaluation, particularly in non-pregnant adults 1
- Consider renal ultrasound to evaluate for obstruction, stones, or anatomic abnormalities 7
Pregnancy-Specific Management
- Any level of GBS bacteriuria in pregnancy (regardless of colony count) requires intrapartum antibiotic prophylaxis at labor or rupture of membranes to prevent neonatal disease 8
- Treat GBS bacteriuria ≥100,000 CFU/mL during pregnancy with oral antibiotics when diagnosed 8
- Do not re-screen pregnant women with documented GBS bacteriuria in the third trimester—they are presumed colonized 8
Antibiotic Resistance Patterns
- Avoid fluoroquinolones, nitrofurantoin, and trimethoprim-sulfamethoxazole as first-line agents for GBS UTI 7, 4
- These agents are optimized for gram-negative organisms and are not reliably effective against GBS 7
- Gentamicin shows variable susceptibility and should not be used 1
- Multidrug resistance in GBS UTI isolates can reach 33.6%, primarily involving macrolides (erythromycin, azithromycin), clindamycin, and tetracycline 6
Common Pitfalls to Avoid
- Do not treat asymptomatic GBS bacteriuria <100,000 CFU/mL in non-pregnant patients, as this does not improve outcomes and promotes resistance 8
- Do not use short-course therapy (3-5 days) appropriate for uncomplicated E. coli cystitis, as GBS UTI requires longer treatment 4
- Do not assume GBS UTI will progress to pyelonephritis at the same rate as E. coli—GBS progresses to pyelonephritis in only 1.1% of cases versus 15.6% for E. coli 9
- Do not use empiric therapy without culture confirmation, as GBS accounts for only 2% of positive urine cultures in non-pregnant adults 1